T. Rowe Price Associates’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $160M | Sell |
539,769
-832,910
| -61% | -$270M | 0.02% | 509 |
|
|
2025
Q4 | $417M | Sell |
1,372,679
-257,892
| -16% | -$84.4M | 0.05% | 289 |
|
|
2025
Q3 | $556M | Buy |
1,630,571
+610,444
| +60% | +$185M | 0.06% | 251 |
|
|
2025
Q2 | $247M | Sell |
1,020,127
-1,693,291
| -62% | -$415M | 0.03% | 389 |
|
|
2025
Q1 | $739M | Sell |
2,713,418
-223,752
| -8% | -$52.3M | 0.09% | 211 |
|
|
2024
Q4 | $543M | Buy |
2,937,170
+237,082
| +9% | +$48.4M | 0.06% | 255 |
|
|
2024
Q3 | $606M | Buy |
2,700,088
+427,266
| +19% | +$76.9M | 0.07% | 250 |
|
|
2024
Q2 | $324M | Buy |
2,272,822
+246,728
| +12% | +$38M | 0.04% | 334 |
|
|
2024
Q1 | $317M | Buy |
2,026,094
+117,905
| +6% | +$19M | 0.04% | 347 |
|
|
2023
Q4 | $344M | Buy |
1,908,189
+158,624
| +9% | +$28.7M | 0.05% | 316 |
|
|
2023
Q3 | $315M | Buy |
1,749,565
+264,691
| +18% | +$52.4M | 0.05% | 311 |
|
|
2023
Q2 | $265M | Buy |
1,484,874
+709,017
| +91% | +$163M | 0.04% | 343 |
|
|
2023
Q1 | $167M | Buy |
775,857
+314,764
| +68% | +$75.5M | 0.03% | 410 |
|
|
2022
Q4 | $101M | Buy |
461,093
+13,676
| +3% | +$2.51M | 0.02% | 489 |
|
|
2022
Q3 | $60.3M | Sell |
447,417
-14,727
| -3% | -$2.53M | 0.01% | 596 |
|
|
2022
Q2 | $74.8M | Sell |
462,144
-64,352
| -12% | -$10.1M | 0.01% | 748 |
|
|
2022
Q1 | $99.3M | Sell |
526,496
-31,264
| -6% | -$6.65M | 0.01% | 734 |
|
|
2021
Q4 | $151M | Sell |
557,760
-13,093
| -2% | -$4.42M | 0.01% | 638 |
|
|
2021
Q3 | $207M | Sell |
570,853
-11,240
| -2% | -$3.67M | 0.02% | 542 |
|
|
2021
Q2 | $200M | Sell |
582,093
-147,837
| -20% | -$49M | 0.02% | 554 |
|
|
2021
Q1 | $254M | Sell |
729,930
-107,448
| -13% | -$35.6M | 0.03% | 486 |
|
|
2020
Q4 | $216M | Buy |
837,378
+50,960
| +6% | +$14M | 0.02% | 507 |
|
|
2020
Q3 | $225M | Buy |
786,418
+189,163
| +32% | +$44.5M | 0.03% | 455 |
|
|
2020
Q2 | $113M | Buy |
597,255
+76,115
| +15% | +$12.4M | 0.01% | 607 |
|
|
2020
Q1 | $64.2M | Sell |
521,140
-68,285
| -12% | -$10.7M | 0.01% | 705 |
|
|
2019
Q4 | $97.7M | Sell |
589,425
-65,170
| -10% | -$10.8M | 0.01% | 676 |
|
|
2019
Q3 | $80.2M | Sell |
654,595
-85,852
| -12% | -$11.4M | 0.01% | 692 |
|
|
2019
Q2 | $91.8M | Sell |
740,447
-61,891
| -8% | -$7.86M | 0.01% | 670 |
|
|
2019
Q1 | $106M | Sell |
802,338
-147,359
| -16% | -$19.9M | 0.02% | 623 |
|
|
2018
Q4 | $133M | Sell |
949,697
-335,086
| -26% | -$44.4M | 0.02% | 535 |
|
|
2018
Q3 | $221M | Sell |
1,284,783
-132,295
| -9% | -$22.2M | 0.03% | 462 |
|
|
2018
Q2 | $218M | Sell |
1,417,078
-2,572
| -0.2% | -$459K | 0.03% | 451 |
|
|
2018
Q1 | $239M | Buy |
1,419,650
+519,130
| +58% | +$70.3M | 0.04% | 414 |
|
|
2017
Q4 | $88M | Sell |
900,520
-67,240
| -7% | -$6.15M | 0.01% | 689 |
|
|
2017
Q3 | $100M | Buy |
967,760
+61,570
| +7% | +$4.59M | 0.02% | 626 |
|
|
2017
Q2 | $40.8M | Sell |
906,190
-129,800
| -13% | -$5.12M | 0.01% | 907 |
|
|
2017
Q1 | $37.9M | Sell |
1,035,990
-33,900
| -3% | -$1.24M | 0.01% | 909 |
|
|
2016
Q4 | $32.5M | Sell |
1,069,890
-32,880
| -3% | -$1.03M | 0.01% | 964 |
|
|
2016
Q3 | $34M | Buy |
1,102,770
+648,370
| +143% | +$18.8M | 0.01% | 936 |
|
|
2016
Q2 | $13.5M | Buy |
454,400
+1,700
| +0.4% | +$49.9K | ﹤0.01% | 1224 |
|
|
2016
Q1 | $13.3M | Buy |
+452,700
| New | +$12.8M | ﹤0.01% | 1202 |
|
Other funds holding ONC
BBA
HA
SL